Search Results - "Ghalib, Reem H"

Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus by Thompson, Alexander J, Muir, Andrew J, Sulkowski, Mark S, Ge, Dongliang, Fellay, Jacques, Shianna, Kevin V, Urban, Thomas, Afdhal, Nezam H, Jacobson, Ira M, Esteban, Rafael, Poordad, Fred, Lawitz, Eric J, McCone, Jonathan, Shiffman, Mitchell L, Galler, Greg W, Lee, William M, Reindollar, Robert, King, John W, Kwo, Paul Y, Ghalib, Reem H, Freilich, Bradley, Nyberg, Lisa M, Zeuzem, Stefan, Poynard, Thierry, Vock, David M, Pieper, Karen S, Patel, Keyur, Tillmann, Hans L, Noviello, Stephanie, Koury, Kenneth, Pedicone, Lisa D, Brass, Clifford A, Albrecht, Janice K, Goldstein, David B, McHutchison, John G

“…Background & Aims We recently identified a polymorphism upstream of interleukin ( IL ) -28B to be associated with a 2-fold difference in sustained virologic…”
Get full text

S1343 Accuracy of FibroScan in Assessing Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease (NAFLD) in a Community Clinic Setting by Al-Assi, Zaid, Ahmed, Faten F., Ghalib, Reem H., Levine, Cheryl D.

Get full text

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection by McHutchison, John G, Lawitz, Eric J, Shiffman, Mitchell L, Muir, Andrew J, Galler, Greg W, McCone, Jonathan, Nyberg, Lisa M, Lee, William M, Ghalib, Reem H, Schiff, Eugene R, Galati, Joseph S, Bacon, Bruce R, Davis, Mitchell N, Mukhopadhyay, Pabak, Koury, Kenneth, Noviello, Stephanie, Pedicone, Lisa D, Brass, Clifford A, Albrecht, Janice K, Sulkowski, Mark S

“…In this randomized comparison of treatment with peginterferon alfa-2a, standard-dose peginterferon alfa-2b, and low-dose peginterferon alfa-2b in patients…”
Get full text

Daclatasvir for previously untreated chronic hepatitis C genotype-1 infection: a randomised, parallel-group, double-blind, placebo-controlled, dose-finding, phase 2a trial by Pol, Stanislas, Dr Prof, Ghalib, Reem H, Prof, Rustgi, Vinod K, Prof, Martorell, Claudia, Prof, Everson, Greg T, Prof, Tatum, Harvey A, Prof, Hézode, Christophe, Prof, Lim, Joseph K, Prof, Bronowicki, Jean-Pierre, Prof, Abrams, Gary A, Prof, Bräu, Norbert, Prof, Morris, David W, Prof, Thuluvath, Paul J, Prof, Reindollar, Robert W, Prof, Yin, Philip D, MD, Diva, Ulysses, PhD, Hindes, Robert, MD, McPhee, Fiona, PhD, Hernandez, Dennis, PhD, Wind-Rotolo, Megan, PhD, Hughes, Eric A, MD, Schnittman, Steven, MD

“…Summary Background Several direct-acting antivirals for chronic hepatitis C virus (HCV) infection are available, but they are limited by tolerability and…”
Get full text

Racial differences in hepatitis C treatment eligibility by Melia, Michael T., Muir, Andrew J., McCone, Jonathan, Shiffman, Mitchell L., King, John W., Herrine, Steven K., Galler, Greg W., Bloomer, Joseph R., Nunes, Frederick A., Brown, Kimberly A., Mullen, Kevin D., Ravendhran, Natarajan, Ghalib, Reem H., Boparai, Navdeep, Jiang, Ruiyun, Noviello, Stephanie, Brass, Clifford A., Albrecht, Janice K., McHutchison, John G., Sulkowski, Mark S.

“…Black Americans are disproportionally infected with hepatitis C virus (HCV) and are less likely than whites to respond to treatment with peginterferon…”
Get full text

SELECT-2 Clinical Trial Assessing the Efficacy and Saftey of Controlled-Release Interferon Alpha-2B (CR2b)+Ribavirin (RBV) Versus Pegylated Interferon Alpha-2B (Peg2b)+RBV in Treatment-NaïVE Genotype-1 (G1) Hepatitis C by Younossi, Zobair M, Lawitz, Eric J, Krastev, Zahary, Rigney, Amy, Tchernev, Konstantin, Takov, Dimitar, Ghalib, Reem H, Long, Walker A

Get full text

M1008 Relationship Between Treatment Related Anemia and SVR Rate in OLT Patients Treated With Peginterferon and Ribavirin by Ghalib, Reem H, Levine, Cheryl D, Cheah, Joann, Watson, Rhoda, Salman, Tayyaba, Rashdan, Sawsan, Alomar, Anas, Mubarak, Abdullah, Mantry, Parvez S, Weinstein, Jeffrey, Anthony, Tiffany, Mejia, Alejandro, Cheng, Stephen

Get full text

M1798 Evaluation of Potential Predictive Factors for SVR in Genotype 2/3 Patients with Cirrhosis by Ghalib, Reem H, Levine, Cheryl D, Mubarak, Abdullah, Mantry, Parvez S, Weinstein, Jeffrey

Get full text

Gender Differences in Hepatitis C Virus (HCV) Treatment Outcomes With Peginterferon (pegIFN) Plus Ribavirin (RBV): An Analysis of the IDEAL Study by Loubser, Kara, Lawitz, Eric J, Shiffman, Mitchell L, McHutchison, John, Muir, Andrew J, Galler, Greg, McCone, Jonathan, Nyberg, Lisa M, Lee, William M, Ghalib, Reem H, Schiff, Eugene R, Long, Jianmin, Noviello, Stephanie, Brass, Clifford A, Pedicone, Lisa D, Albrecht, Janice K, Sulkowski, Mark

Get full text

Infections During Peginterferon (pegIFN)/Ribavirin (RBV) Therapy Are Associated With a Decline in Lymphocyte Count: Results of the IDEAL Study by Melia, Michael, Brau, Norbert, Poordad, Fred, Lawitz, Eric J, Shiffman, Mitchell L, McHutchison, John, Muir, Andrew J, Galler, Greg, McCone, Jonathan, Nyberg, Lisa M, Lee, William M, Ghalib, Reem H, Schiff, Eugene R, Long, Jianmin, Noviello, Stephanie, Brass, Clifford A, Pedicone, Lisa D, Albrecht, Janice K, Sulkowski, Mark

Get full text

Thyroid Stimulating Hormone (TSH) and Peginterferon Treatment Induced Hypothyroidism May Be Associated With Phosphodiesterase Polymorphisms in Patients With Chronic Hepatitis C by Clark, Paul, Thompson, Alexander J, Zhu, Mingfu, Ge, Dongliang, Shianna, Kevin, Tillmann, Hans L, Patel, Keyur, Urban, Thomas, Singh, Abanish, Sulkowski, Mark, Afdhal, Nezam, Jacobson, Ira M, Esteban, Rafael, Poordad, Fred, Lawitz, Eric J, McCone, Jonathan, Shiffman, Mitchell L, Galler, Greg, Lee, William M, Reindollar, Robert W, King, John W, Kwo, Paul Y, Ghalib, Reem H, Freilich, Bradley, Nyberg, Lisa M, Noviello, Stephanie, Boparai, Navdeep, Koury, Kenneth, Pedicone, Lisa D, Brass, Clifford A

Get full text

S1006 Increased LFTS/Clinical Liver Failure in Post OLT Patients Being Treated with Pegifn Alfa-2B Plus Ribavirin for Recurrent Hepatitis C by Ghalib, Reem H, Levine, Cheryl D, Hollinger, F Blaine, Stribling, Rise, Box, Terry D, Hutson, William, Post, Anthony B, Joshi, Shobha N, Regenstein, Fredric, Weinstein, Jeffrey, Goss, John A, Mejia, Alejandro, Cheng, Stephen

Get full text

Assessment of the Patient Who Failed Treatment for Chronic Hepatitis C by Levine, Cheryl D, Ghalib, Reem H

“…Chronic hepatitis C virus (HCV) infection affects more than 4 million people in the United States and 170 million people in the world, making it a major public…”
Get full text

Efficacy and safety of MK-5172 and MK-8742 +/- ribavirin in hepatitis C genotype 1 infected patients with cirrhosis or previous null response: Final results of the C-WORTHY Study (Parts A and B) by Lawitz, Eric, Gane, Edward J., Pearlman, Brian, Tam, Edward, Ghesquiere, Wayne, Guyader, Dominique, Alric, Laurent, Bronowicki, Jean-Pierre, Rossaro, Lorenzo, Sievert, William, Ghalib, Reem H., Balart, Luis A., Sund, Fredrik, Lagging, Martin, Dutko, Frank, Howe, Anita Y., Shaughnessy, Melissa, Hwang, Peggy, Wahl, Janice, Robertson, Michael, Haber, Barbara A.

Get full text

Treatment of recurrent hepatitis C after liver transplantation with pegylated interferon alfa-2b plus ribavirin. Preliminary analysis by Ghalib, Reem H., Levine, Cheryl D., Stribling, Rise, McClelland, Tricia, Box, Terry D., Hutson, William R., Post, Anthony B., Regenstein, Fredric G., Zubi, Ayman, Seu, Philip, Goss, John

Get full text

762 Safety and efficacy of PEG IFN alfa-2B plus ribavirin for recurrent hepatitis C after liver transplantation: a preliminary analysis by Ghalib, Reem H., Levine, Cheryl D., Stribling, Rise, McClelland, Tricia, Box, Terry D., Hutson, William R., Post, Anthony B., Regenstein, Fredric G., Goshi, Shobha, Weinstein, Jeffrey, Seu, Philip, Goss, John, Cheng, Steven

Get full text

776 Changes in hemoglobin during therapy with PEG IFN alfa-2B plus ribavirin in patients with recurrent hepatitis C after liver transplantation by Ghalib, Reem H., Levine, Cheryl D., Hollinger, Blaine, Stribling, Rise, McClelland, Tricia, Box, Terry D., Hutson, William R., Post, Anthony B., Regenstein, Fredric G., Goshi, Shobha, Weinstein, Jeffrey, Simon, Fay, Seu, Philip, Goss, John, Cheng, Steven

Get full text

Hepatitis C: role of the advanced practice nurse by Clark, C H, Ghalib, R H

“…Hepatitis C virus (HCV) is a common but insidious and indolent viral infection that can lead to chronic hepatitis, cirrhosis, and hepatocellular carcinoma…”
Get more information